The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- COVID-19 (76)
- Advertising (65)
- COVID-19 vaccines (30)
- Medicine safety (27)
- Regulatory compliance (17)
- Labelling and packaging (8)
- Legislation (8)
- Listed medicines (8)
- Non-prescription medicines (8)
- Prescription medicines (8)
- Therapeutic goods regulation (8)
- Vaping hub (8)
- Assessed listed medicines (6)
- Complementary medicines (4)
- Safety (4)
- Manufacturing (3)
- Medical devices safety (3)
- Medicinal cannabis hub (3)
- Over the counter (OTC) medicines (3)
- Alert/Advisory (2)
- In Vitro Diagnostic medical devices (IVDs) (2)
- Scheduling (national classification system) (2)
- Advisory bodies and committees (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Blood safety (1)
- Compliance and enforcement hub (1)
- Import and export (1)
- Shortages (1)
- Sunscreens (1)
- Travelling with health products (1)
- Weight loss products (1)
Search
209 result(s) found, displaying 1 to 25
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
NewsThe Prescribing Medicines in Pregnancy database has now been updated.
-
NewsThe Generic Medicines Work-Sharing Initiative has updated its Operational Procedures document and Expression Of Interest form.
-
Media releasesTravellers will be able to bring up to 3-months supply of their medicine.
-
Therapeutic Goods (Biologicals-Application Form for Priority Applicant Determinations) Approval 2022
NoticesApproval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations) -
NewsBefore you take a weight loss supplement or medicine, there are things to consider.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
BlogMake small changes to how you think about paracetamol.
-
Safety updatesMedicines Safety Update - Information for health professionals
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsA warning to social media influencers and advertisers not to advertise this prescription medicine.
-
Media releasesThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products in Australia.
-
NoticesListed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
-
Media releasesThe TGA has issued an infringement notice of $2,664 to a NSW-based medical practitioner for alleged unlawful advertising of nicotine vaping products in a social media post.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
Media releasesThe TGA has granted a provisional determination to Pfizer's bivalent COVID-19 vaccine candidate: tozinameran & famtozinameran (COMIRNATY BIVALENT OMICRON BA.4/BA.5 COVID-19 VACCINE).
-
NoticesArrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 61(3)(a), 61(5AA), and 61(5AB) of the Act
-
Media releasesOn 25 October 2022, Natural Franchises Pty Ltd pleaded guilty in a Sydney court to over 200 offences of the Therapeutic Goods Act 1989 for the manufacture, supply and advertising of unapproved therapeutic goods.
-
Media releasesThe TGA is calling for anyone using a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine to see if they are affected by the recall action.
-
COVID-19 vaccine safety reportsInformation about the TGA's safety monitoring of COVID-19 vaccines.
-
NewsFind out about the requirements starting on 1 January 2023 for medicines that are serialised or include a data matrix code.
-
Media releasesThe TGA has issued one infringement notice to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.
-
Safety updatesMedicines Safety Update - Information for health professionals.
-
Media releasesThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on a website and through social media.